Anti-setd3 monoclonal antibody and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- WUHAN UNIV
- Publication Date
- 2022-06-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and relates to an anti-SETD3 monoclonal antibody and its application. Background technique
[0002] SETD3 is a member of the methyltransferase family containing the SET domain, which is close to SETD4 and SETD6 proteins in terms of kinship and structure. The secondary structure of SETD3 mainly includes catalytic domain (SET domain) and substrate binding domain (Rubis-subs-bind domain). SETD3 is relatively conserved in different species, and its homologous protein has not been found in yeast. In humans, SETD3 is expressed in a variety of tissues, with the highest expression in testis and skeletal muscle. In the process of myoblast differentiation, SETD3 can promote the differentiation of skeletal muscle; SETD3 and FoxM1 are combined in the promoter region of vascular endothelial growth factor (vascular endothelial-derived growth factor, VEGF) signaling pathway and negatively regulate the expression ...